Skip to content

Insider · CIK 0001836301

Michelle Seitz

director

Files at MET (METLIFE INC), MSCI (MSCI Inc.), SANA (Sana Biotechnology, Inc.), HONA (Honeywell Aerospace Inc.). First filing -, latest -.

In brief

Michelle Seitz files SEC Form 4 as director at MET (METLIFE INC), and also at MSCI (MSCI Inc.), SANA (Sana Biotechnology, Inc.), HONA (Honeywell Aerospace Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michelle Seitz has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026MET
METLIFE INC
AGrant or award
Common Stock
+544$0.00$02,1258 d ago
Aug 3, 2026HONA
Honeywell Aerospace Inc.
AGrant or award
Restricted Stock Unitsderivative
+572$0.00$0572Aug 5, 2026
Jun 29, 2026HONA
Honeywell Aerospace Inc.
AGrant or award
Deferred Compensation (Phantom Shares)derivative
+135$226.24$31k135Jul 1, 2026
Jun 16, 2026MET
METLIFE INC
AGrant or award
Common Stock
+587$0.00$01,581Jun 18, 2026
Jun 4, 2026SANA
Sana Biotechnology, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+90,000$0.00$090,000Jun 5, 2026
May 1, 2026MSCI
MSCI Inc.
AGrant or award
Common Stock
+388$0.00$01,059May 5, 2026
Apr 1, 2026MET
METLIFE INC
AGrant or award
Common Stock
+721$0.00$0994Apr 3, 2026
Feb 24, 2026MET
METLIFE INC
AGrant or award
Common Stock
+273$0.00$0273Feb 26, 2026
Jun 5, 2025SANA
Sana Biotechnology, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+80,000$0.00$080,000Jun 9, 2025
May 1, 2025MSCI
MSCI Inc.
AGrant or award
Common Stock
+385$0.00$0671May 5, 2025

Questions about Michelle Seitz

Answered from the filings on this page, as of the latest one.

Is Michelle Seitz buying or selling?

Michelle Seitz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michelle Seitz's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michelle Seitz has 0.

Where does Michelle Seitz file Form 4?

Michelle Seitz has filed Form 4 at MET (METLIFE INC); MSCI (MSCI Inc.); SANA (Sana Biotechnology, Inc.); HONA (Honeywell Aerospace Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michelle Seitz: insider trades and track record | InsiderTell